Shares of aerospace and defense company Heico (HEI.US) have pulled back to their lowest level since May 2025 and continue their downward momentum amid concerns over airline industry conditions in the context of conflicts in the Middle East and rising jet fuel prices. The prospect of fewer flights may translate into lower demand for repairs and spare parts, potentially putting pressure on revenue growth in the medium term. Although the company reported record results for the last quarter, the market has generally been repricing companies with exposure to the civil aerospace sector, and Heico’s revenue mix is roughly balanced between commercial and defense segments.
Moreover, in recent quarters it has been the commercial segment that has grown faster. The market has used the uncertain environment as an opportunity to take profits, with the stock now down ุญูุงูู 20% from its historical peak — the largest decline since spring last year. It is worth noting, however, that while the company is pro-cyclical, it has historically navigated downturns successfully and remains one of the top long-term performers among publicly listed companies since 1990. Investors continue to pay a significant premium for the stock, with the forward 12-month P/E ratio close to 50, and price-to-sales and price-to-book ratios around 9.
Heico (HEI.US)
The current drawdown relative to the 200-session EMA (EMA200) stands at around 10%, a level that has historically been rare and, between 2020 and 2026, consistently followed by demand-driven rebounds. If the Strait of Hormuz is unblocked in the near term, this could act as a strong catalyst for the stock. If disruptions persist, however, the market may continue to approach the company with caution.
Source: xStation5
DAX down 12% from all-time high ๐ฉWatch this 2 stocks in April
Daily summary: Hopes for peace and space stocks in the spotlight
Globalstar: Are we headed for a battle of giants over orbit?
Intuitive Machines: Flywheel of the space economy?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
